Brief: Fresenius Says Sale In Two Independent Steps Accelerates Divestment Of Vamed’s Austrian Activities
Oct 10 (Reuters) - Fresenius SE & Co KGaA FREG.DE: SALE IN TWO INDEPENDENT STEPS SIMPLIFIES AND ACCELERATES DIVESTMENT OF VAMED’S AUSTRIAN ACTIVITIES IN-DEPTH TALKS ONGOING WITH STRABAG ON SALE OF VIENNA GENERAL HOSPITAL (AKH WIEN) OPERATIONS BUSINESS FRESENIUS AND PORR SIGNED AN AGREEMENT TODAY ON THE SALE OF AUSTRIAN PROJECT Source text: [ID:] Further company coverage: FREG.DE (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com ; +48 587785269;;))
Recent news on Fresenius SE & Co. KGaA
See all newsFresenius lifts 2026 expectations after strong Q3 (updated)
Healthcare firm Fresenius Q3 revenue rises on Kabi growth; lifts outlook
Brief: Fresenius Sees FY26 EBIT Margin Above 11.5%
Brief: Fresenius SE Q3 Revenue EUR 5,803 Million
Fresenius signs biosimilars pipeline agreement with WuXi Biologics (updated)